Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 GermlineCausalMutation disease ORPHANET Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721) shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. 19684605 2009
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 GermlineCausalMutation disease ORPHANET Further evidence that variants in PPP1CB cause a rasopathy similar to Noonan syndrome with loose anagen hair. 27868344 2017
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 GermlineCausalMutation disease ORPHANET A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair. 27264673 2016
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 GermlineCausalMutation disease ORPHANET The recurrent PPP1CB mutation p.Pro49Arg in an additional Noonan-like syndrome individual: Broadening the clinical phenotype. 28211982 2017
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease CLINGEN Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells. 22606262 2012
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease CLINGEN The RASopathies. 23875798 2013
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease CLINGEN SHOC2 subcellular shuttling requires the KEKE motif-rich region and N-terminal leucine-rich repeat domain and impacts on ERK signalling. 27466182 2016
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease GENOMICS_ENGLAND Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721) shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. 19684605 2009
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease CLINGEN Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies. 20882035 2010
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease CLINGEN Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype. 21548061 2011
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease BEFREE Erbin blocks ERK signaling by interacting with and disrupting Ras-Raf scaffolds mediated by SHOC2, a protein genetically linked to the RASopathy, Noonan-like syndrome with loose anagen hair (NS/LAH). 23524970 2013
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease CLINGEN Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721) shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. 19684605 2009
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease GENOMICS_ENGLAND Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis. 23918763 2013
Entrez Id: 8036
Gene Symbol: SHOC2
SHOC2
0.700 Biomarker disease GENOMICS_ENGLAND The RASopathies. 23875798 2013
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 Biomarker disease CLINGEN A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair. 27264673 2016
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 Biomarker disease CLINGEN The recurrent PPP1CB mutation p.Pro49Arg in an additional Noonan-like syndrome individual: Broadening the clinical phenotype. 28211982 2017
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 Biomarker disease CLINGEN A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. 16630891 2006
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 Biomarker disease CLINGEN De novo mutations in moderate or severe intellectual disability. 25356899 2014
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 Biomarker disease CLINGEN An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth. 24211266 2013
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 Biomarker disease CLINGEN De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease. 27681385 2016
Entrez Id: 5500
Gene Symbol: PPP1CB
PPP1CB
0.510 Biomarker disease CLINGEN Further evidence that variants in PPP1CB cause a rasopathy similar to Noonan syndrome with loose anagen hair. 27868344 2017
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.300 Biomarker disease CLINGEN
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
0.300 Biomarker disease CLINGEN
Entrez Id: 5921
Gene Symbol: RASA1
RASA1
0.300 Biomarker disease CLINGEN
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.300 Biomarker disease CLINGEN Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp. 28371260 2017